Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Orchard Therapeutics

Biotech & Life Sciences · London, United Kingdom · Founded 2015 · IPO 2018 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$303M
Market cap · 2026
Revenue
$20M
Latest reported FY

Investors

20 investors on Orchard Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
F-Prime
Series B+ 19 investors entered at this stage
ArrowMark Partners
Juda Capital
Baillie Gifford
Deerfield
4BIO Capital
RA Capital Management
ORI Capital
Venrock
UCL Technology Fund
Cowen Group
Perceptive Advisors
Pavilion Capital Partners
Cormorant Asset Management
Foresite Capital
University College London
RTW Investments
AlbionVC
Agent Capital
Temasek

Global footprint

Where Orchard Therapeutics has talent and traffic

AI talent share
0.4% of workforce is AI talent
(1 of 239 staff)
Core AI00%
Other AI10.42%
Non-AI workforce23899.58%
Web traffic by country
11K monthly visits
across markets
🇺🇸 United States69.1%
🇬🇧 United Kingdom11.8%
🇮🇳 India7.3%
🇫🇷 France6.4%
🇵🇭 Philippines1.8%
Top 5 markets shown

See Orchard Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo